Related factors for worsening renal function following percutaneous transluminal renal angioplasty (PTRA) in patients with atherosclerotic renal artery stenosis

Purpose: To identify candidates for PTRA in terms of the preservation of renal function, we herein evaluated factors that caused worsening renal function (WRF) after PTRA. Methods: We evaluated 92 patients with atherosclerotic renal artery stenosis (mean age 70.7 ± 8.4 years). WRF was defined as a ≥...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental hypertension (1993) Vol. 37; no. 7; pp. 526 - 530
Main Authors Yoshihara, Fumiki, Fukuda, Tetsuya, Iwashima, Yoshio, Nakamura, Satoko, Hayashi, Shin-Ichiro, Kishida, Masatsugu, Ishizuka, Azusa, Kusunoki, Hiroshi, Ohta, Yuko, Kawano, Yuhei
Format Journal Article
LanguageEnglish
Published England Informa Healthcare 03.10.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose: To identify candidates for PTRA in terms of the preservation of renal function, we herein evaluated factors that caused worsening renal function (WRF) after PTRA. Methods: We evaluated 92 patients with atherosclerotic renal artery stenosis (mean age 70.7 ± 8.4 years). WRF was defined as a ≥0.3 mg/dL increase in creatinine levels after PTRA compared to before PTRA. Results: A total of 92 patients exhibited non-WRF 83 (90.2%), WRF 9 (9.8%). Significant differences were observed in serum creatinine levels between two groups both before (non-WRF 1.34 ± 0.49 versus WRF 1.70 ± 0.68 mg/dL, p = 0.0462) and after PTRA (non-WRF 1.31 ± 0.43 versus WRF 2.42 ± 1.12 mg/dL, p < 0.0001). Patients with WRF had higher comorbidity rate of diabetes mellitus (DM) (non-WRF 31.3% versus WRF 66.7%, p = 0.0345) and proteinuria (non-WRF 27.7% versus WRF 66.7%, p = 0.0169), and had higher systolic blood pressure (non-WRF 143.6 ± 18.7 versus WRF 157.1 ± 19.9 mmHg, p = 0.0436), higher plasma B-type natriuretic peptide (BNP) levels, and larger left atrial and left ventricular end-diastolic dimensions before PTRA. Patients with WRF had a higher rate of taking diuretics (non-WRF 27.7% versus WRF 66.7%, p = 0.0169) after PTRA. Multiple logistic regression analysis revealed that comorbidity of DM was an independent related factor for WRF (comorbidity of DM, yes: OR 31.0, 95% CI 2.44-1024.62, p = 0.0055). Conclusions: Comorbidity of DM, coexisting of proteinuria, high creatinine level, high blood pressure, high BNP levels, and large left atrial and ventricular dimensions were related to WRF after PTRA in patients with atherosclerotic renal artery stenosis.
AbstractList PURPOSETo identify candidates for PTRA in terms of the preservation of renal function, we herein evaluated factors that caused worsening renal function (WRF) after PTRA.METHODSWe evaluated 92 patients with atherosclerotic renal artery stenosis (mean age 70.7 ± 8.4 years). WRF was defined as a ≥0.3 mg/dL increase in creatinine levels after PTRA compared to before PTRA.RESULTSA total of 92 patients exhibited non-WRF 83 (90.2%), WRF 9 (9.8%). Significant differences were observed in serum creatinine levels between two groups both before (non-WRF 1.34 ± 0.49 versus WRF 1.70 ± 0.68 mg/dL, p = 0.0462) and after PTRA (non-WRF 1.31 ± 0.43 versus WRF 2.42 ± 1.12 mg/dL, p < 0.0001). Patients with WRF had higher comorbidity rate of diabetes mellitus (DM) (non-WRF 31.3% versus WRF 66.7%, p = 0.0345) and proteinuria (non-WRF 27.7% versus WRF 66.7%, p = 0.0169), and had higher systolic blood pressure (non-WRF 143.6 ± 18.7 versus WRF 157.1 ± 19.9 mmHg, p = 0.0436), higher plasma B-type natriuretic peptide (BNP) levels, and larger left atrial and left ventricular end-diastolic dimensions before PTRA. Patients with WRF had a higher rate of taking diuretics (non-WRF 27.7% versus WRF 66.7%, p = 0.0169) after PTRA. Multiple logistic regression analysis revealed that comorbidity of DM was an independent related factor for WRF (comorbidity of DM, yes: OR 31.0, 95% CI 2.44-1024.62, p = 0.0055).CONCLUSIONSComorbidity of DM, coexisting of proteinuria, high creatinine level, high blood pressure, high BNP levels, and large left atrial and ventricular dimensions were related to WRF after PTRA in patients with atherosclerotic renal artery stenosis.
Purpose: To identify candidates for PTRA in terms of the preservation of renal function, we herein evaluated factors that caused worsening renal function (WRF) after PTRA. Methods: We evaluated 92 patients with atherosclerotic renal artery stenosis (mean age 70.7 ± 8.4 years). WRF was defined as a ≥0.3 mg/dL increase in creatinine levels after PTRA compared to before PTRA. Results: A total of 92 patients exhibited non-WRF 83 (90.2%), WRF 9 (9.8%). Significant differences were observed in serum creatinine levels between two groups both before (non-WRF 1.34 ± 0.49 versus WRF 1.70 ± 0.68 mg/dL, p = 0.0462) and after PTRA (non-WRF 1.31 ± 0.43 versus WRF 2.42 ± 1.12 mg/dL, p < 0.0001). Patients with WRF had higher comorbidity rate of diabetes mellitus (DM) (non-WRF 31.3% versus WRF 66.7%, p = 0.0345) and proteinuria (non-WRF 27.7% versus WRF 66.7%, p = 0.0169), and had higher systolic blood pressure (non-WRF 143.6 ± 18.7 versus WRF 157.1 ± 19.9 mmHg, p = 0.0436), higher plasma B-type natriuretic peptide (BNP) levels, and larger left atrial and left ventricular end-diastolic dimensions before PTRA. Patients with WRF had a higher rate of taking diuretics (non-WRF 27.7% versus WRF 66.7%, p = 0.0169) after PTRA. Multiple logistic regression analysis revealed that comorbidity of DM was an independent related factor for WRF (comorbidity of DM, yes: OR 31.0, 95% CI 2.44-1024.62, p = 0.0055). Conclusions: Comorbidity of DM, coexisting of proteinuria, high creatinine level, high blood pressure, high BNP levels, and large left atrial and ventricular dimensions were related to WRF after PTRA in patients with atherosclerotic renal artery stenosis.
To identify candidates for PTRA in terms of the preservation of renal function, we herein evaluated factors that caused worsening renal function (WRF) after PTRA. We evaluated 92 patients with atherosclerotic renal artery stenosis (mean age 70.7 ± 8.4 years). WRF was defined as a ≥0.3 mg/dL increase in creatinine levels after PTRA compared to before PTRA. A total of 92 patients exhibited non-WRF 83 (90.2%), WRF 9 (9.8%). Significant differences were observed in serum creatinine levels between two groups both before (non-WRF 1.34 ± 0.49 versus WRF 1.70 ± 0.68 mg/dL, p = 0.0462) and after PTRA (non-WRF 1.31 ± 0.43 versus WRF 2.42 ± 1.12 mg/dL, p < 0.0001). Patients with WRF had higher comorbidity rate of diabetes mellitus (DM) (non-WRF 31.3% versus WRF 66.7%, p = 0.0345) and proteinuria (non-WRF 27.7% versus WRF 66.7%, p = 0.0169), and had higher systolic blood pressure (non-WRF 143.6 ± 18.7 versus WRF 157.1 ± 19.9 mmHg, p = 0.0436), higher plasma B-type natriuretic peptide (BNP) levels, and larger left atrial and left ventricular end-diastolic dimensions before PTRA. Patients with WRF had a higher rate of taking diuretics (non-WRF 27.7% versus WRF 66.7%, p = 0.0169) after PTRA. Multiple logistic regression analysis revealed that comorbidity of DM was an independent related factor for WRF (comorbidity of DM, yes: OR 31.0, 95% CI 2.44-1024.62, p = 0.0055). Comorbidity of DM, coexisting of proteinuria, high creatinine level, high blood pressure, high BNP levels, and large left atrial and ventricular dimensions were related to WRF after PTRA in patients with atherosclerotic renal artery stenosis.
Author Kusunoki, Hiroshi
Nakamura, Satoko
Kawano, Yuhei
Fukuda, Tetsuya
Kishida, Masatsugu
Ohta, Yuko
Ishizuka, Azusa
Hayashi, Shin-Ichiro
Yoshihara, Fumiki
Iwashima, Yoshio
Author_xml – sequence: 1
  givenname: Fumiki
  surname: Yoshihara
  fullname: Yoshihara, Fumiki
  email: fyoshi@hsp.ncvc.go.jp
  organization: Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center
– sequence: 2
  givenname: Tetsuya
  surname: Fukuda
  fullname: Fukuda, Tetsuya
  organization: Department of Radiology, National Cerebral and Cardiovascular Center
– sequence: 3
  givenname: Yoshio
  surname: Iwashima
  fullname: Iwashima, Yoshio
  organization: Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center
– sequence: 4
  givenname: Satoko
  surname: Nakamura
  fullname: Nakamura, Satoko
  organization: Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center
– sequence: 5
  givenname: Shin-Ichiro
  surname: Hayashi
  fullname: Hayashi, Shin-Ichiro
  organization: Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center
– sequence: 6
  givenname: Masatsugu
  surname: Kishida
  fullname: Kishida, Masatsugu
  organization: Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center
– sequence: 7
  givenname: Azusa
  surname: Ishizuka
  fullname: Ishizuka, Azusa
  organization: Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center
– sequence: 8
  givenname: Hiroshi
  surname: Kusunoki
  fullname: Kusunoki, Hiroshi
  organization: Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center
– sequence: 9
  givenname: Yuko
  surname: Ohta
  fullname: Ohta, Yuko
  organization: Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center
– sequence: 10
  givenname: Yuhei
  surname: Kawano
  fullname: Kawano, Yuhei
  organization: Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25919953$$D View this record in MEDLINE/PubMed
BookMark eNp9kctu3CAUhlGVqLm0j9CKZbrwhIuxza5R1CaVIjWKkrXF4ENChcEFrNG8TR-1WJ7pshtAOt9_DvBdoBMfPCD0iZINp0ReU9LUVDZ8wwgVG0oop0y8Q-dUMFE1hDQn5VyYaoHO0EVKvwihdSO69-iMCUmlFPwc_XkCpzIM2CidQ0zYhIh35QDe-lccwSuHzex1tsGXonNhtxQmiHrOykOYE85R-eTm0S7wGlH-1YbJqZT3-Orx-enmC7YeTypb8Dnhnc1vWOU3iCFpV9Zs9TEZM8Q9Thl8SDZ9QKdGuQQfD_slevn-7fn2vnr4effj9uah0ryrcwUNEBiYVoob2dWyE0wRIg03XJiuA7nlAgTRrerqhkmlG7rVbUvkwMxWs4Zfoqu17xTD7xlS7kebNDi3vrGnLWulpIzRgooV1eX2KYLpp2hHFfc9Jf0ipz_K6Rc5_UFOyX0-jJi3Iwz_UkcbBfi6AtYXDaMqHtzQZ7V3IZryx9qmpf__ZvwFTbmk1A
Cites_doi 10.1291/hypres.27.985
10.1161/01.CIR.0000153271.77341.9F
10.1046/j.1523-1755.2003.00734.x
10.1007/s00380-003-0723-y
10.1291/hypres.31.433
10.1583/03-1062.1
10.1097/HJH.0000000000000160
10.1056/NEJM200102083440603
10.1016/0002-9149(86)90771-X
10.1177/152660280200900419
10.1053/j.ajkd.2008.12.034
10.1056/NEJMoa0905368
10.1053/j.ajkd.2013.07.020
10.1056/NEJMoa1310753
10.1111/j.1523-1755.2005.00534.x
10.1161/CIRCULATIONAHA.106.174526
ContentType Journal Article
Copyright 2015 Taylor & Francis Group, LLC. 2015
Copyright_xml – notice: 2015 Taylor & Francis Group, LLC. 2015
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.3109/10641963.2015.1013125
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1525-6006
EndPage 530
ExternalDocumentID 10_3109_10641963_2015_1013125
25919953
1013125
Genre Articles
Journal Article
GroupedDBID ---
00X
03L
0BK
0R~
0YH
29B
36B
4.4
5GY
5RE
AAJNR
AALUX
AAMIU
AAPUL
AAPXX
AAQRR
ABBKH
ABDBF
ABEIZ
ABLKL
ABPTK
ABUPF
ACENM
ACFUF
ACGEJ
ACGFS
ACLSK
ADCVX
ADFCX
ADRBQ
ADXPE
AECIN
AENEX
AEOZL
AEYQI
AFKVX
AFWLO
AGDLA
AGFJD
AGRBW
AIJEM
AIRBT
AJWEG
AKBVH
ALIIL
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AMDAE
BABNJ
BLEHA
BOHLJ
CCCUG
CS3
DKSSO
DU5
EAP
EAS
EBC
EBD
EBS
EHN
EJD
EMB
EMK
EMOBN
EPL
EPT
ESX
F5P
H13
HZ~
KRBQP
KSSTO
KWAYT
KYCEM
M4Z
O9-
Q~Q
RNANH
RVRKI
SV3
TFDNU
TFL
TFW
TUS
UEQFS
V1S
~1N
.GJ
34G
39C
53G
5VS
AALIY
AAORF
ABJNI
ABLIJ
ABWCV
ABXYU
ABZEW
ACKZS
ADFOM
ADFZZ
AEIIZ
AFLEI
AGYJP
AI.
AJVHN
ALYBC
AWYRJ
BRMBE
CAG
CGR
COF
CUY
CVF
CYYVM
CZDIS
DRXRE
DWTOO
ECM
EIF
GROUPED_DOAJ
JENTW
LJTGL
M44
NPM
NUSFT
QQXMO
TBQAZ
TDBHL
TERGH
TUROJ
VH1
ZXP
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c384t-e6e0ed2caa3f9849852a009f3f35f88e9b35e50c7a84629ac61bc7709d2fbc263
ISSN 1064-1963
IngestDate Sat Oct 26 00:16:15 EDT 2024
Tue Oct 22 03:31:21 EDT 2024
Tue Oct 15 23:52:01 EDT 2024
Tue Jun 13 20:01:10 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords B-type natriuretic peptide
Blood pressure
diabetes mellitus
left ventricular dimension
left atrial dimension
percutaneous transluminal renal angioplasty
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c384t-e6e0ed2caa3f9849852a009f3f35f88e9b35e50c7a84629ac61bc7709d2fbc263
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 25919953
PQID 1727991221
PQPubID 23479
PageCount 5
ParticipantIDs informaworld_taylorfrancis_310_3109_10641963_2015_1013125
pubmed_primary_25919953
proquest_miscellaneous_1727991221
crossref_primary_10_3109_10641963_2015_1013125
PublicationCentury 2000
PublicationDate 2015-10-03
PublicationDateYYYYMMDD 2015-10-03
PublicationDate_xml – month: 10
  year: 2015
  text: 2015-10-03
  day: 03
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Clinical and experimental hypertension (1993)
PublicationTitleAlternate Clin Exp Hypertens
PublicationYear 2015
Publisher Informa Healthcare
Publisher_xml – name: Informa Healthcare
References CIT0001
CIT0012
CIT0011
Mehran R (CIT0010) 2004; 44
George T (CIT0006) 2011; 22
CIT0003
CIT0014
CIT0002
CIT0013
CIT0005
CIT0016
CIT0004
CIT0015
CIT0007
CIT0018
CIT0017
CIT0009
CIT0008
CIT0019
References_xml – ident: CIT0007
  doi: 10.1291/hypres.27.985
– ident: CIT0016
  doi: 10.1161/01.CIR.0000153271.77341.9F
– ident: CIT0012
  doi: 10.1046/j.1523-1755.2003.00734.x
– ident: CIT0005
  doi: 10.1007/s00380-003-0723-y
– volume: 44
  start-page: 1393
  year: 2004
  ident: CIT0010
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Mehran R
– ident: CIT0002
  doi: 10.1291/hypres.31.433
– ident: CIT0013
  doi: 10.1583/03-1062.1
– ident: CIT0017
  doi: 10.1583/03-1062.1
– ident: CIT0018
  doi: 10.1097/HJH.0000000000000160
– ident: CIT0014
  doi: 10.1056/NEJM200102083440603
– ident: CIT0008
  doi: 10.1016/0002-9149(86)90771-X
– ident: CIT0011
  doi: 10.1177/152660280200900419
– ident: CIT0009
  doi: 10.1053/j.ajkd.2008.12.034
– ident: CIT0003
  doi: 10.1056/NEJMoa0905368
– ident: CIT0001
  doi: 10.1053/j.ajkd.2013.07.020
– ident: CIT0004
  doi: 10.1056/NEJMoa1310753
– ident: CIT0019
  doi: 10.1111/j.1523-1755.2005.00534.x
– volume: 22
  start-page: 531
  year: 2011
  ident: CIT0006
  publication-title: Saudi J Kidney Dis Transpl
  contributor:
    fullname: George T
– ident: CIT0015
  doi: 10.1161/CIRCULATIONAHA.106.174526
SSID ssj0014658
Score 2.090462
Snippet Purpose: To identify candidates for PTRA in terms of the preservation of renal function, we herein evaluated factors that caused worsening renal function (WRF)...
To identify candidates for PTRA in terms of the preservation of renal function, we herein evaluated factors that caused worsening renal function (WRF) after...
PURPOSETo identify candidates for PTRA in terms of the preservation of renal function, we herein evaluated factors that caused worsening renal function (WRF)...
SourceID proquest
crossref
pubmed
informaworld
SourceType Aggregation Database
Index Database
Publisher
StartPage 526
SubjectTerms Aged
Angioplasty - adverse effects
Angioplasty - methods
B-type natriuretic peptide
Blood pressure
diabetes mellitus
Diabetes Mellitus - epidemiology
Female
Humans
Hypertension - diagnosis
Hypertension - epidemiology
Hypertrophy, Left Ventricular - diagnosis
Kidney - physiopathology
Kidney Function Tests - methods
Kidney Function Tests - statistics & numerical data
left atrial dimension
left ventricular dimension
Male
Natriuretic Peptide, Brain - analysis
percutaneous transluminal renal angioplasty
Renal Artery - pathology
Renal Artery - surgery
Renal Artery Obstruction - diagnosis
Renal Artery Obstruction - physiopathology
Renal Artery Obstruction - surgery
Renal Insufficiency - diagnosis
Renal Insufficiency - etiology
Renal Insufficiency - physiopathology
Risk Factors
Title Related factors for worsening renal function following percutaneous transluminal renal angioplasty (PTRA) in patients with atherosclerotic renal artery stenosis
URI https://www.tandfonline.com/doi/abs/10.3109/10641963.2015.1013125
https://www.ncbi.nlm.nih.gov/pubmed/25919953
https://search.proquest.com/docview/1727991221
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1tb9MwELZKJyG-IN4pbzISH0AoI7FjN_nYDaaBNISgk8anyEmdrerWTG2iavwafiG_gTvbSd1pIF6-RJHTi608T-27892ZkBcSTOSJLMpAR4UKYilVkAseBrnKI5GUZao0JicffJT7h_GHI3HU6_3wopaaOt8uvl2ZV_IvqEIb4IpZsn-BbPdSaIB7wBeugDBc_whjE8kGGmN7aA6GDK7gRhtnx0KjpokLl4snPD2tVib5XC-KBpRCjeGvNS5WMEOZ07GsiJofT6tzUKtrEwrwafx5hM6DdRXWNiUOlcdqCYNaVLYUtJHGINGL18CeebWcLn3td7dNw0Rv_cbZAidgDi9MML1hY4IBf56T4mu1PJliaWmja8NgZ9OOeM2smZj2sa6XzUW3zLxf4TlRZ-aRka86x7eaqbPGvuyLqqtZ5fs-IlMzNeRre3gjYwtD5byZHHStAKcXu9C52Z2JADQ86U__tuaMo_nQm8sFk55aIOz20eUVh9uCrdgbdoaxggI9Ijyy-dyXinm7J9fIFsPK_n2yNdp5u7PX7XvFUtjkTTd4m3OGnby5sosNbWqj1u6vLSajOY1vkZvO5KEjy9_bpKfnd8j1AxfUcZd8dzSmjsYUXk87GlPDKtrSmHY0pj6NqU9jJ-LRmL5EEr-i0zltKUyRwvQShVtJQ2HaUvgeOdx7N97dD9zBIUHBk7gOtNShnrBCKV6mSZwmgimwJUpeclEmiU5zLrQIi6EC7ZulqpBRXgyHYTphZV4wye-T_rya64eExkmoIp7HWkoWw-_VEFpYkUo5KUuQHpDtFoDs3NaHycCuRsSyFrEMEcscYgOS-jBltXHMlfYUHZT7rezzFtMMVgHc2rMfOUMzBCw9xqIBeWDB7obDRIp1GPij_-j5Mbmx_v89If160einoI3X-TNH4Z_Jj-Sc
link.rule.ids 315,786,790,27946,27947
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Related+factors+for+worsening+renal+function+following+percutaneous+transluminal+renal+angioplasty+%28PTRA%29+in+patients+with+atherosclerotic+renal+artery+stenosis&rft.jtitle=Clinical+and+experimental+hypertension+%281993%29&rft.au=Yoshihara%2C+Fumiki&rft.au=Fukuda%2C+Tetsuya&rft.au=Iwashima%2C+Yoshio&rft.au=Nakamura%2C+Satoko&rft.date=2015-10-03&rft.pub=Informa+Healthcare&rft.issn=1064-1963&rft.eissn=1525-6006&rft.volume=37&rft.issue=7&rft.spage=526&rft.epage=530&rft_id=info:doi/10.3109%2F10641963.2015.1013125&rft.externalDocID=1013125
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1064-1963&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1064-1963&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1064-1963&client=summon